Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Novo Nordisk reported Friday that its experimental obesity drug CagriSema led to a 22.7% weight loss in late-stage trials, falling short of the expected 25% and wiping out as much as $125 billion in market value
Even though they continued to get injected every week for three more years, they didnt lose any more weight over the subsequent 143 weeks
Eisfeld, K., Riffer, F., Mentges, J
Conclusion: GLP-1RAs appear to reduce pain in patients with knee osteoarthritis, likely through weight reduction
US$ 25.40
US$ 22.18
US$ 21.37
US$ 25.63
US$ 28.79
US$ 27.76
US$ 27.12
US$ 26.90
US$ 23.38
